1727. Phase 1b Dose-ranging Study Demonstrates Tolerability and Pharmacokinetics (PK) of Oral Epetraborole at the Predicted Therapeutic Dosage for <i>Mycobacterium avium</i> Complex (MAC) Lung Disease
Open forum infectious diseases